Which medication classification is most often associated with the side effects of gynecomastia, amenorrhea, and galactorrhea?

Choice A rationale Anticholinergic medications primarily block acetylcholine receptors, commonly leading to side effects like dry mouth, blurred vision, constipation, and urinary retention. They do not typically cause hyperprolactinemia-related effects such as gynecomastia (male breast enlargement), amenorrhea (absence of menstruation), or galactorrhea (milky discharge). Choice B rationale First-generation (conventional) antipsychotics, like haloperidol, exert a potent Dopamine-2 receptor antagonism in the tuberoinfundibular pathway. This blockade lifts the dopaminergic inhibition on prolactin release from the anterior pituitary, resulting in hyperprolactinemia, which is the direct cause of gynecomastia, amenorrhea, and galactorrhea. Choice C rationale Second-generation (atypical) antipsychotics also block D2 receptors but often have a broader receptor profile. While some (like risperidone) can cause hyperprolactinemia, others are prolactin-sparing or cause it less frequently or severely than the first-generation agents. Choice D rationale Third-generation antipsychotics, such as aripiprazole, are often dopamine system stabilizers (partial agonists). They are less likely to cause significant D2 blockade and often have a lower risk of inducing hyperprolactinemia and the associated endocrine side effects compared to both first- and some second-generation agents.